MoneyWorks4Me

Emmessar Biotech&Nut - Quaterly Results

09 Dec 2023 Evaluate
The September 2023 quarter revenue stood at Rs. 0.84 millions, up 23.53% as compared to Rs. 0.68 millions during the corresponding quarter last year.An average growth of 45.19% was recorded for the quarter ended September 2023 to Rs. 1.96  millions from Rs. 1.35 millions.Operating profit surged to 3.11 millions from the corresponding previous quarter of 2.28 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 0.84 0.68 23.53 1.52 2.76 -44.93 10.19 3.65 179.18
Other Income 5.27 4.32 21.99 9.84 8.73 12.71 17.51 19.19 -8.75
PBIDT 3.11 2.28 36.40 4.95 5.16 -4.07 10.60 10.25 3.41
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 3.11 2.28 36.40 4.95 5.16 -4.07 10.60 10.25 3.41
Depreciation 0.24 0.23 4.35 0.48 0.46 4.35 0.94 0.92 2.17
PBT 2.87 2.05 40.00 4.47 4.70 -4.89 9.66 9.33 3.54
TAX 0.91 0.70 30.00 1.96 1.40 40.00 4.63 4.57 1.31
Deferred Tax 0.10 -0.30 -133.33 0.70 0.40 75.00 2.12 0.22 863.64
PAT 1.96 1.35 45.19 2.51 3.30 -23.94 5.03 4.76 5.67
Equity 49.96 49.96 0.00 49.96 49.96 0.00 49.96 49.96 0.00
PBIDTM(%) 370.24 335.29 10.42 325.66 186.96 74.19 104.02 280.82 -62.96
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..